Pralatrexate Injection [Folotyn]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2010

2010

Identification of An Active, Well-Tolerated Dose of Pralatrexate In Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma (CTCL): Final Results of a Multicenter Dose-Finding Study.

S. Horwitz, Y. H. Kim, +11 authors M. Duvic
2010

Corpus ID: 208350671

Abstract 2800 Background: Pralatrexate (FOLOTYN®) is an antifolate designed for preferential tumor uptake and accumulation… Expand